US Patent

US7888364 — Pyridyl inhibitors of hedgehog signalling

Composition of Matter · Assigned to Curis Inc · Expires 2028-11-11 · 2y remaining

Vulnerability score 22/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects novel compounds with the general formula I that inhibit hedgehog signaling, useful for treating malignancies.

USPTO Abstract

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R 1 , R 2 , R 3 , R 4 , m and n are as described herein.

Drugs covered by this patent

Patent Metadata

Patent number
US7888364
Jurisdiction
US
Classification
Composition of Matter
Expires
2028-11-11
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Curis Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.